相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
Susan W. Barnetta et al.
AIDS (2008)
Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo
Luzheng Liu et al.
BMC IMMUNOLOGY (2008)
Chronic innate immune activation as a cause of HIV-1 immunopathogenesis
Adriano Boasso et al.
CLINICAL IMMUNOLOGY (2008)
Human versus HIV: round 2 defeat in AIDS vaccine development
Shan Lu
EXPERT REVIEW OF VACCINES (2008)
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Alexandre Harari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?
Rafick-Pierre Sekaly
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Measuring HIV-1-specific T cell immunity: How valid are current assays?
M. Patricia D'Souza et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity
Michael S. Bennett et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection
Qingsheng Li et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells
Marybeth Daucher et al.
JOURNAL OF VIROLOGY (2008)
Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery
Keith Mansfield et al.
JOURNAL OF VIROLOGY (2008)
Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells
David Verhoeven et al.
JOURNAL OF VIROLOGY (2008)
HIV-1 T-cell vaccines: evaluating the next step
Giuseppe Pantaleo
LANCET INFECTIOUS DISEASES (2008)
Vaccine trial provided valuable information
David Baltimore
NATURE (2008)
Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut
Manuela Raffatellu et al.
NATURE MEDICINE (2008)
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
David I. Watkins et al.
NATURE MEDICINE (2008)
CD8+ T cell efficacy in vaccination and disease
Victor Appay et al.
NATURE MEDICINE (2008)
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: Dominant site of antibody neutralization and target for vaccine design
Marinieve Montero et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
Perspective - HIV vaccine research: The way forward
Anthony S. Fauci et al.
SCIENCE (2008)
Mucosal immunity and HIV/AIDS vaccines - Report of an International Workshop, 28-30 October 2007
Marc P. Girard et al.
VACCINE (2008)
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers
Shixia Wang et al.
VACCINE (2008)
Improving defences at the portal of HIV entry: mucosal and innate immunity - A summary report from a global HIV vaccine enterprise working group
Robin J. Shattock et al.
PLOS MEDICINE (2008)
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis
Andrea Gori et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Recognition of escape variants in ELISPOT does not always predict CD8(+) T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences
Laura E. Valentine et al.
JOURNAL OF VIROLOGY (2008)
Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses
Yun Li et al.
JOURNAL OF VIROLOGY (2008)
Human immunodeficiency virus type 1 vaccine development: Recent advances in the cytotoxic T-lymphocyte platform Spotty Business
Kimberly A. Schoenly et al.
JOURNAL OF VIROLOGY (2008)
Sublingual immunization induces broad-based systemic and mucosal immune responses in mice
Nicolas Cuburu et al.
VACCINE (2007)
Atraumatic oral spray immunization with replication-deficient viral vector vaccines
Christiane Stahl-Hennig et al.
JOURNAL OF VIROLOGY (2007)
Replicating and non-replicating viral vectors for vaccine development
Marjorie Robert-Guroff
CURRENT OPINION IN BIOTECHNOLOGY (2007)
HIV/AIDS vaccines: 2007
H. L. Robinson
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid
Jean D. Boyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Understanding the benign nature of SIV infection in natural hosts
Guido Silvestri et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
Jorge R. Almeida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of Tat in viral replication
Atze T. Das et al.
JOURNAL OF VIROLOGY (2007)
DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity
L. Buonaguro et al.
VACCINE (2007)
Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets
S. Phogat et al.
JOURNAL OF INTERNAL MEDICINE (2007)
A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells
Igor M. Belyakov et al.
JOURNAL OF IMMUNOLOGY (2007)
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors
Kimberly McCoy et al.
JOURNAL OF VIROLOGY (2007)
Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: Antigenicity, biophysics, and immunogenicity
Barna Dey et al.
JOURNAL OF VIROLOGY (2007)
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection
J. William Critchfield et al.
JOURNAL OF VIROLOGY (2007)
Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques
Amara Luckay et al.
JOURNAL OF VIROLOGY (2007)
Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine
Miki Kawada et al.
JOURNAL OF VIROLOGY (2007)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
Asier Saez-Cirion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A CD46-binding chimpanzee adenovirus vector as a vaccine carrier
Nia Tatsis et al.
MOLECULAR THERAPY (2007)
Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication
Chungwon Chung et al.
JOURNAL OF VIROLOGY (2007)
Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity
Jorma Hinkula
EXPERT REVIEW OF VACCINES (2007)
Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein
Rong Xu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge:: Role of SIV-specific CD8+ T cell responses
Nina V. Malkevitch et al.
VIROLOGY (2006)
HIV-specific antibodies but not T-Cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia
Marie Nguyen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Systemic vaccination prevents the total destruction of mucosal CD4 T cells during acute SIV challenge
Joseph J. Mattapallil et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2006)
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
Shixia Wang et al.
VIROLOGY (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys
NL Letvin et al.
SCIENCE (2006)
Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649-684, a mucosal subunit HIV/AIDS vaccine candidate
Nobuyuki Matoba et al.
VACCINE (2006)
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
Nancy A. Wilson et al.
JOURNAL OF VIROLOGY (2006)
Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation
Gillis R. Otten et al.
VACCINE (2006)
A dose sparing effect by plasmid encoded IL-12 adjuvant on a SlVgag-plasmid DNA vaccine in rhesus macaques
Eva B. Schadeck et al.
VACCINE (2006)
HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently
Emma L. Turnbull et al.
JOURNAL OF IMMUNOLOGY (2006)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa
IM Belyakov et al.
BLOOD (2006)
HIV disease: fallout from a mucosal catastrophe?
JM Brenchley et al.
NATURE IMMUNOLOGY (2006)
Translating innate immunity into immunological memory: Implications for vaccine development
B Pulendran et al.
CELL (2006)
Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques
M Kawada et al.
JOURNAL OF VIROLOGY (2006)
Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes
Z Hel et al.
JOURNAL OF IMMUNOLOGY (2006)
HIV vaccine design: insights from live attenuated SIV vaccines
WC Koff et al.
NATURE IMMUNOLOGY (2006)
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques
AB McDermott et al.
JOURNAL OF VIROLOGY (2005)
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
DR Casimiro et al.
JOURNAL OF VIROLOGY (2005)
Perils at mucosal front lines for HIV and SIV and their hosts
AT Haase
NATURE REVIEWS IMMUNOLOGY (2005)
Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
J Zhou et al.
VACCINE (2005)
T cell vaccines for microbial infections
HL Robinson et al.
NATURE MEDICINE (2005)
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
PB Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin
L Lopalco et al.
JOURNAL OF GENERAL VIROLOGY (2005)
DNA vaccines against human immunodeficiency virus type 1 in the past decade
M Giri et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Protection against mucosal simian immunodeficiency virus SIVmac251 challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting
LJ Patterson et al.
JOURNAL OF VIROLOGY (2004)
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
JM Brenchley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
S Mehandru et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs
N Matoba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein
SI Staprans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
DNA/MVA vaccine for HIV type 1: Effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime
JM Smith et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity
C Devito et al.
JOURNAL OF IMMUNOLOGY (2004)
Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial
T Matano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Enhanced sensitivity of detection of cytotoxic T lymphocyte responses to HIV type 1 proteins using an extended in vitro stimulation period for measuring effector function in volunteers enrolled in an ALVAC-HIV phase I/II prime boost vaccine trial in Thailand
W Kantakamalakul et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Induction of HIV immunity in intranasal delivery of a MVA the genital tract after vector:: Enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule
MM Gherardi et al.
JOURNAL OF IMMUNOLOGY (2004)
Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition
M Koch et al.
VIROLOGY (2003)
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination:: Efficient human cell infection and bypass of preexisting adenovirus immunity
R Vogels et al.
JOURNAL OF VIROLOGY (2003)
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
M Pope et al.
NATURE MEDICINE (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor
B Dey et al.
JOURNAL OF VIROLOGY (2003)
A simian replication-defective vaccine to HIV-1 gag
JC Fitzgerald et al.
JOURNAL OF IMMUNOLOGY (2003)
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239
TU Vogel et al.
JOURNAL OF VIROLOGY (2003)
Entry of viruses through the epithelial barrier: Pathogenic trickery
M Bomsel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques
T Fouts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Alphavirus vectors and vaccination
JO Rayner et al.
REVIEWS IN MEDICAL VIROLOGY (2002)
Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV
WD Xu et al.
VACCINE (2002)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
JW Shiver et al.
NATURE (2002)
Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women
L Bélec et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans
EL Johansson et al.
INFECTION AND IMMUNITY (2001)
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein
L Deml et al.
JOURNAL OF VIROLOGY (2001)
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
PWHI Parren et al.
JOURNAL OF VIROLOGY (2001)
Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1
A Alfsen et al.
JOURNAL OF IMMUNOLOGY (2001)
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
RR Amara et al.
SCIENCE (2001)
In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail
PN Fultz et al.
JOURNAL OF VIROLOGY (2001)
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
DH Barouch et al.
SCIENCE (2000)
Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate
C Devito et al.
AIDS (2000)
The prime-boost strategy: exciting prospects for improved vaccination
IA Ramshaw et al.
IMMUNOLOGY TODAY (2000)
分享论文
